STERIS plc (STE) Earnings Call Transcripts

STERIS plc's Latest Earnings Call - Q4 FY2026

In the fourth quarter of fiscal 2026, STERIS plc reported total revenue growth of 7%, with adjusted earnings per share increasing 3% to $2.83. The company maintained its guidance for fiscal 2027, projecting revenue growth of 7% to 8% and adjusted EPS of $11.10 to $11.30, reflecting a 9% to 11% increase year-over-year. Management highlighted a strong financial position, with free cash flow of $982.9 million and a commitment to capital allocation priorities, including a $1 billion share buyback authorization.

Reported metrics

Guidance from management

Management expects fiscal 2027 revenue growth of 7% to 8% and adjusted EPS between $11.10 and $11.30. EBIT margins are anticipated to expand approximately 50 basis points, assuming flat tariff spending year-over-year.

What management said

All right. Thanks, Brett. We appreciate the question. I'll add a little bit of light on this, and then Karen is going to pepper in a little bit more of a response on some of the details around tariffs and et cetera. I think there's a few things that we're going to work on really hard to maximize that 50 bps, and that's really going to be some operational improvements. as well as a continued sell-through of our high...

Yes, really more specific to the AST comps. We started the year last year, first couple of quarters in double-digit growth in that business. and then saw a bit of a slowdown in Q3 where we saw some inventory flow back from our customers. And then this past quarter got a little weird just with the snowstorms. We probably lost time 150 to 200 basis points of growth there. So if you sort of stack all that up, I think on...

What analysts pressed on

Analysts expressed concerns regarding the impact of tariffs and inflation on margins, particularly in the AST segment. There were also questions about the cautious outlook for the first half of fiscal 2027 due to difficult comparisons and inventory management by med tech customers.

Main topics on the call

• Revenue Growth and Guidance — STERIS reported total revenue of approximately $6 billion for fiscal 2026, with 9% growth year-over-year. For fiscal 2027, management expects as-reported revenue growth of 7% to 8%, driven by tuck-in acquisitions contrib...
• Earnings Performance — Adjusted earnings per diluted share for the quarter were $2.83, reflecting a 3% increase year-over-year. Management indicated that the adjusted EPS outlook for fiscal 2027 is between $11.10 and $11.30, representing a gro...
• Margin Pressure and Tariffs — The EBIT margin for the fourth quarter was 24.2%, down 60 basis points from the prior year due to inflation and tariffs. Management noted that incremental tariffs impacted the quarter by approximately $10 million, but th...
• Free Cash Flow and Capital Allocation — Free cash flow for fiscal 2026 was strong at $982.9 million, allowing for a $1 billion share buyback authorization. Management plans to consistently buy back shares in the range of $200 million to $300 million per year.

Read the full STERIS plc transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 34 STERIS plc earnings call transcripts on record, spanning February 11, 2020 to May 12, 2026. Based on this history, STERIS plc reports quarterly. The most recent call on file is dated May 12, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

STE

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

34

First call

February 11, 2020

Most recent

May 12, 2026

Reporting cadence

quarterly